Nonclinical services for the development of interventional agents for infectious diseases
Ended Awarded Last action
- Contract number
- 75N93023F00001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,272,027
Award facts
- Contract value 100% obligated
- $2,272,027.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $543,705 | |
| Original award | $1,728,322 |
About this award
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $2.27 million delivery order contract to Sri International under the prime contractor's existing Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity master contract. The 24-month contract calls for Sri International to provide nonclinical services for the development of interventional agents to address infectious diseases. Major subcontractors include VDX for histology lab processing, Experimental Pathology Laboratories for pathology services, and Marshall Bioresources for supplying male and female Gottingen minipigs for testing. The contract work will be performed in West Menlo Park, California and supports the funding agency's programs involving preclinical research and development of medical countermeasures against infectious disease threats.
Quick answers
Who was awarded contract 75N93023F00001?
75N93023F00001 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on November 1, 2022.
How much is contract 75N93023F00001 worth?
The government has obligated $2,272,027 on 75N93023F00001.
Is contract 75N93023F00001 an order under another contract?
Yes. 75N93023F00001 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93023F00001 competed?
The extent of competition for 75N93023F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award